ASCO 2023 - Utility of circulating tumor DNA (ctDNA) as a predictive biomarker for disease monitoring in patients (pts) with cholangiocarcin Published Date June 7, 2023 Expand Fullscreen Exit Fullscreen Download PDF Expand Fullscreen